Zobrazeno 1 - 10
of 6 807
pro vyhledávání: '"Adoptive immunotherapy"'
Publikováno v:
International Journal of Nanomedicine, Vol Volume 19, Pp 12311-12321 (2024)
Ting-ting Li,1 Jin-hua Yang,1 Meng-jie Jiang,1 Hao-peng Cui,1 Xiao-mei Yang,2 Xiao-ling Lu,2 Ai-qun Liu1 1Department of Gastroenterology and Respiratory Medicine & Endoscopy Center, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, 530021
Externí odkaz:
https://doaj.org/article/04758f093c6a4869b5112b2c99ae7c3f
Autor:
Elena A. Golikova, Alina A. Alshevskaya, Saleh Alrhmoun, Natalia A. Sivitskaya, Sergey V. Sennikov
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-17 (2024)
Abstract TCR-T cell therapy represents a promising advancement in adoptive immunotherapy for cancer treatment. Despite its potential, the development and preclinical testing of TCR-T cells face significant challenges. This review provides a structure
Externí odkaz:
https://doaj.org/article/5b713d088eb846389f371cede8d9d4c7
Publikováno v:
Breast Cancer: Targets and Therapy, Vol Volume 16, Pp 497-516 (2024)
Qian-Er Wen,1 Liang Li,1 Rui-Qi Feng,1 De-Hui Li,2 Chang Qiao,1 Xiao-Song Xu,3 Yan-Jing Zhang2 1Graduate School, Hebei University of Chinese Medicine, Shijiazhuang, Hebei Province, People’s Republic of China; 2Oncology Department II, The First Affi
Externí odkaz:
https://doaj.org/article/3cfd4ce1d9b1400b92b70eee86ee6d5d
Publikováno v:
Inflammation and Regeneration, Vol 44, Iss 1, Pp 1-10 (2024)
Abstract Adoptive immunotherapy, in which tumor-reactive T cells are prepared in vitro for adoptive transfer to the patient, can induce an objective clinical response in specific types of cancer. In particular, chimeric antigen receptor (CAR)-redirec
Externí odkaz:
https://doaj.org/article/a76d4c3cc4c54db79d1df4db972e596e
Autor:
Xin Hu, Yifang Shui, Seiichi Shimizu, Seisuke Sakamoto, Mureo Kasahara, Seiji Okada, Wen-Zhi Guo, Masayuki Fujino, Xiao-Kang Li
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 58, Iss , Pp 101061- (2024)
Natural killer (NK) cells are a promising cellular therapy for T cell-refractory cancers but are frequently deficient or dysfunctional in patients with hepatocellular carcinoma (HCC). In the present study, we explored a novel therapy for HCC using NK
Externí odkaz:
https://doaj.org/article/b9245aade97b4907a32f994cffdd2697
Autor:
Mariko Takami, Shinichiro Motohashi
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Invariant natural killer T (iNKT) cells are a small subset of T lymphocytes that release large amounts of cytokines such as IFN-γ and exhibit cytotoxic activity upon activation, inducing strong anti-tumor effects. Harnessing the anti-tumor propertie
Externí odkaz:
https://doaj.org/article/450718aa1ed049a999d568f026b7aae4
Autor:
Paula Ercilla-Rodríguez, Marta Sánchez-Díez, Nicolás Alegría-Aravena, Josefa Quiroz-Troncoso, Clara E. Gavira-O'Neill, Raquel González-Martos, Carmen Ramírez-Castillejo
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Immunotherapy has made significant strides in cancer treatment with strategies like checkpoint blockade antibodies and adoptive T cell transfer. Chimeric antigen receptor T cells (CAR-T) have emerged as a promising approach to combine these strategie
Externí odkaz:
https://doaj.org/article/c22b11043f324518b114847e057c70ee
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionAdoption of allogeneic T cells directly supplements the number of T cells and rapidly induces T-cell immunity, which has good efficacy for treating some tumors and immunodeficiency diseases. However, poor adoptive T-cell engraftment and g
Externí odkaz:
https://doaj.org/article/88dc86c0d6c941d9aa9a7dce2f8e7185
Autor:
Abbas Hajifathali, Maryam Vahdat Lasemi, Maryam Mehravar, Mohammad Reza Moshari, Afshin Mohammad Alizadeh, Elham Roshandel
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss 1, Pp 58-66 (2024)
Introduction: Chimeric Antigen Receptor (CAR) T cells have tremendous potentials for cancer treatment; however, various challenges impede their universal use. These restrictions include the poor function of T cells in tumor microenvironments, the sho
Externí odkaz:
https://doaj.org/article/821d6dd967814410ad748efafdb11bfe
Autor:
Na Zheng, Yihao Long, Zixuan Bai, Jianing Li, Hongyu Wang, Dan-Dan Song, Hong-Lin Liu, Jian-Hong Shi, Shuli Zhao
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-11 (2024)
Abstract Background Chimeric antigen receptor CAR-T cell therapies have ushered in a new era of treatment for specific blood cancers, offering unparalleled efficacy in cases of treatment resistance or relapse. However, the emergence of cytokine relea
Externí odkaz:
https://doaj.org/article/45ee568115be4b51a9edc9b64b7df583